IDR 50.0
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 744.63 Million IDR | -37.87% |
2022 | 1.19 Billion IDR | -96.28% |
2021 | 32.23 Billion IDR | -4.37% |
2020 | 33.71 Billion IDR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -21.94 Million IDR | 99.08% |
2024 Q1 | -2.39 Billion IDR | -1.9% |
2023 Q2 | -5.59 Billion IDR | -696.21% |
2023 FY | 744.63 Million IDR | -37.87% |
2023 Q1 | 938.59 Million IDR | 0.0% |
2022 FY | 1.19 Billion IDR | -96.28% |
2021 FY | 32.23 Billion IDR | -4.37% |
2020 FY | 33.71 Billion IDR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
PT Mark Dynamics Indonesia Tbk | 191.39 Billion IDR | 99.611% |
PT Hetzer Medical Indonesia Tbk | -2.5 Billion IDR | 129.741% |
PT Jayamas Medica Industri Tbk | 302.56 Billion IDR | 99.754% |